CHARLES RIVER LABORATORIES (CRL) Stock Income Statement
NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD
| TTM (2025-3-29) | 2024 (2024-12-28) | 2023 (2023-12-30) | 2022 (2022-12-31) | 2021 (2021-12-25) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.02B | 4.05B | 4.13B | 3.98B | 3.54B | |||
| Minority Interest Expense | -8.25M | -14.99M | -5.75M | -6.38M | -7.86M | |||
| Cost Of Goods | 2.63B | 2.64B | 2.60B | 2.51B | 2.21B | |||
| Gross Profit | 1.40B | 1.41B | 1.53B | 1.46B | 1.33B | |||
| Operating Expenses | 888.91M | 857.11M | 869.86M | 802.94M | 701.65M | |||
| Selling, General, and Administrative Expenses | 717.75M | 718.64M | 732.42M | 656.36M | 576.79M | |||
| Operating Income | 506.37M | 550.83M | 659.32M | 659.72M | 632.99M | |||
| Interest Income/Expense | -132.89M | -130.61M | -131.51M | -58.51M | -74.86M | |||
| Other Income/Expense | -13.06M | -3.62M | -27.86M | 10.52M | -56.99M | |||
| Non Recurring Items | -330.33M | -323.49M | 81.34M | 11.26M | -20.42M | |||
| Income Before Taxes | 30.08M | 93.11M | 581.28M | 622.99M | 480.71M | |||
| Income Tax | 53.39M | 67.82M | 100.91M | 130.38M | 81.87M | |||
| Net Income | -31.56M | 10.30M | 474.62M | 486.23M | 390.98M | |||
| EBITDA | 903.12M | 912.57M | 973.45M | 963.59M | 898.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.65 | 0.20 | 9.22 | 9.48 | 7.60 | |||
| Non GAAP EPS | 10.39 | 10.32 | 10.65 | 11.13 | 10.33 | |||
| Statistics | ||||||||
| Gross Profit Margin | 34.69% | 34.76% | 37.03% | 36.79% | 37.70% | |||
| Profit Margin | -0.78% | 0.25% | 11.49% | 12.23% | 11.04% | |||
| Operating Profit Margin | 12.59% | 13.60% | 15.97% | 16.59% | 17.88% | |||
All data in USD